Volume 17, Number 9—September 2011
Research
Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England
Table 3
Multivariable analysis of all study participants in relation to having ARI or serology-confirmed infection during outbreak of pandemic (H1N1) 2009, England*
Variable | AOR (95% CI) for ARI in questionnaire sample | AOR (95% CI) for positive test result in matched sample |
---|---|---|
Age group, y | ||
13–15 | 1 | 1 |
16–18 | 1.57 (0.98–2.53) | 1.85 (0.95–3.60) |
20–49 | 1.00 (0.53–1.89) | 0.30 (0.12–0.73) |
>50 |
0.66 (0.32–1.34) |
0.20 (0.08–0.53) |
Took antiviral drugs for PEP† | ||
No | 1 | |
Yes |
0.41 (0.27–0.61) |
0.55 (0.30–0.99) |
Seasonal Influenza vaccine | ||
No | 1 | 1 |
Yes | 1.01 (0.63–1.62) | 1.81 (0.91–3.59) |
*For ARI, n = 654 who completed questionnaires; for serology-confirmed infection, n = 333 who completed questionnaires and had a matched serology sample. ARI, acute respiratory infection; AOR, adjusted odds ratio; CI, confidence interval; PEP, postexposure prophylaxis.
†Persons who reported taking treatment dose of antiviral agents were excluded.